Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FIH Study of Oral CXA-10 in Healthy Volunteers
NCT02313064Phase 1Completed
- Sponsor
- Complexa Therapeutics
- Start
- Jan 2015
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of 10-nitro-oleic acid in chronic kidney disease (CKD) (3 arms), sponsored by Complexa Therapeutics. Primary endpoint: Number of subjects with Serious and Non-Serious Adverse Events. Started Jan 2015; status: completed.
02
Drugs
10-nitro-oleic acid
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT02313064.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02313064.